Wanting Xu

1.6k total citations
64 papers, 1.1k citations indexed

About

Wanting Xu is a scholar working on Molecular Biology, Toxicology and Organic Chemistry. According to data from OpenAlex, Wanting Xu has authored 64 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 17 papers in Toxicology and 12 papers in Organic Chemistry. Recurrent topics in Wanting Xu's work include Bioactive Compounds and Antitumor Agents (17 papers), Synthesis and biological activity (10 papers) and Genomics, phytochemicals, and oxidative stress (6 papers). Wanting Xu is often cited by papers focused on Bioactive Compounds and Antitumor Agents (17 papers), Synthesis and biological activity (10 papers) and Genomics, phytochemicals, and oxidative stress (6 papers). Wanting Xu collaborates with scholars based in China, United States and Hong Kong. Wanting Xu's co-authors include Diane G. Edmondson, Sharon Y. Roth, Cheng‐Hao Jin, Ying‐Hua Luo, Richard R. Behringer, Yvonne A. Evrard, Maki Wakamiya, Hui Xue, Xian‐Ji Piao and Tong Zhang and has published in prestigious journals such as Nature Genetics, Molecular and Cellular Biology and Langmuir.

In The Last Decade

Wanting Xu

57 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wanting Xu China 19 730 127 110 101 99 64 1.1k
Jiajie Guo China 18 763 1.0× 134 1.1× 121 1.1× 115 1.1× 68 0.7× 51 1.4k
Junshan Liu China 20 695 1.0× 139 1.1× 80 0.7× 90 0.9× 94 0.9× 57 1.2k
Tianqi Ming China 11 595 0.8× 71 0.6× 66 0.6× 186 1.8× 57 0.6× 16 1.1k
Siddik Sarkar India 23 627 0.9× 66 0.5× 78 0.7× 346 3.4× 77 0.8× 54 1.5k
Nathaniel B. Goldstein United States 13 625 0.9× 42 0.3× 38 0.3× 141 1.4× 105 1.1× 18 1.3k
Brooke J. Marfell Australia 10 573 0.8× 45 0.4× 35 0.3× 131 1.3× 95 1.0× 10 1.2k
Xiaoping Wu China 22 864 1.2× 111 0.9× 30 0.3× 185 1.8× 96 1.0× 81 1.4k
Qinghua Liu China 17 617 0.8× 69 0.5× 47 0.4× 47 0.5× 75 0.8× 56 1.1k
Berthold Büchele Germany 23 1.0k 1.4× 76 0.6× 60 0.5× 87 0.9× 43 0.4× 35 1.7k
Sarah D. Lamore United States 22 598 0.8× 38 0.3× 31 0.3× 134 1.3× 110 1.1× 29 1.4k

Countries citing papers authored by Wanting Xu

Since Specialization
Citations

This map shows the geographic impact of Wanting Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanting Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanting Xu more than expected).

Fields of papers citing papers by Wanting Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanting Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanting Xu. The network helps show where Wanting Xu may publish in the future.

Co-authorship network of co-authors of Wanting Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Wanting Xu. A scholar is included among the top collaborators of Wanting Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanting Xu. Wanting Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Fang, et al.. (2025). Progress and strategies in advanced aerospace materials for extreme environments: A review. Acta Astronautica. 238. 184–196. 1 indexed citations
2.
Zhang, Yimeng, Wanting Xu, Xianbao Shen, et al.. (2025). Metal-free Fenton-like system with adjustable singlet oxygen/electron transfer ratio mediated by lignin: pollutant structure dependent activity. Chemical Engineering Journal. 525. 170694–170694. 1 indexed citations
3.
Xia, Yang, Panwen Tian, Mo Zhou, et al.. (2025). Ensartinib for advanced or metastatic non-small-cell lung cancer with MET exon 14 skipping mutations (EMBRACE): a multi-center, single-arm, phase 2 trial. EClinicalMedicine. 81. 103099–103099. 2 indexed citations
4.
Wang, Yiran, Wanting Xu, Tao Shen, et al.. (2024). Models predicting mortality risk of patients with burns to ≥ 50% of the total body surface. Burns. 50(5). 1277–1285. 1 indexed citations
5.
Xu, Wanting, Xianbao Shen, Ying Wu, et al.. (2024). Lignin regulating the active sites and peroxymonosulfate activation capacities of iron incorporated 1D carbon nanofiber for efficient organic pollutant degradation. Separation and Purification Technology. 354. 129156–129156. 2 indexed citations
6.
Wang, Yiran, Wanting Xu, Zexin Chen, et al.. (2024). Ultra-restrictive red blood cell transfusion strategies in extensively burned patients. Scientific Reports. 14(1). 2848–2848. 1 indexed citations
8.
Xu, Wanting, et al.. (2024). The prognostic value and model construction of inflammatory markers for patients with non-small cell lung cancer. Scientific Reports. 14(1). 7568–7568. 4 indexed citations
9.
Zhang, Xiaoli, Jiali Lin, Mohammad Hassan Sohouli, et al.. (2023). Effects of NAD+ precursors on blood pressure, C‐reactive protein concentration and carotid intima‐media thickness: A meta‐analysis of randomized controlled trials. European Journal of Clinical Investigation. 53(12). e14078–e14078. 1 indexed citations
11.
Dong, Lei, Mengchuan Xu, Yang Li, et al.. (2023). SMURF1 attenuates endoplasmic reticulum stress by promoting the degradation of KEAP1 to activate NRF2 antioxidant pathway. Cell Death and Disease. 14(6). 361–361. 11 indexed citations
12.
Luo, Ying‐Hua, Cheng Wang, Wanting Xu, et al.. (2021). 18β-Glycyrrhetinic Acid Has Anti-Cancer Effects via Inducing Apoptosis and G2/M Cell Cycle Arrest, and Inhibiting Migration of A549 Lung Cancer Cells. OncoTargets and Therapy. Volume 14. 5131–5144. 32 indexed citations
13.
Sheng, Yanan, Ying‐Hua Luo, Shaobin Liu, et al.. (2020). <p>Zeaxanthin Induces Apoptosis via ROS-Regulated MAPK and AKT Signaling Pathway in Human Gastric Cancer Cells</p>. OncoTargets and Therapy. Volume 13. 10995–11006. 55 indexed citations
14.
Lin, Xinmei, Shaobin Liu, Ying‐Hua Luo, et al.. (2020). 10‐HDA Induces ROS‐Mediated Apoptosis in A549 Human Lung Cancer Cells by Regulating the MAPK, STAT3, NF‐κB, and TGF‐β1 Signaling Pathways. BioMed Research International. 2020(1). 3042636–3042636. 38 indexed citations
15.
Li, Shasha, et al.. (2020). Interleukin-17A promotes the differentiation of bone marrow mesenchymal stem cells into neuronal cells. Tissue and Cell. 69. 101482–101482. 7 indexed citations
16.
Zhang, Jin, Liqun Zhao, Xin Cheng, et al.. (2019). Rational Design of a Chimeric Derivative of PcrV as a Subunit Vaccine Against Pseudomonas aeruginosa. Frontiers in Immunology. 10. 781–781. 30 indexed citations
17.
Xu, Wanting, et al.. (2019). Giant urethral calculus in anterior urethral diverticulum: a case report. BMC Urology. 19(1). 71–71. 7 indexed citations
18.
Xu, Wanting, Guinan Shen, Ying‐Hua Luo, et al.. (2019). New naphthalene derivatives induce human lung cancer A549 cell apoptosis via ROS-mediated MAPKs, Akt, and STAT3 signaling pathways. Chemico-Biological Interactions. 304. 148–157. 16 indexed citations
19.
Xu, Wanting, Ying‐Hua Luo, Yue Wang, et al.. (2017). Apoptotic Effect of Quinalizarin on Human Hepatoma Huh7 Cells and Its Antitumor Mechanism. Zhongliu fangzhi yanjiu. 44(7). 454–459. 1 indexed citations
20.
Xu, Wanting, Diane G. Edmondson, Yvonne A. Evrard, et al.. (2000). Loss of Gcn5l2 leads to increased apoptosis and mesodermal defects during mouse development. Nature Genetics. 26(2). 229–232. 197 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026